Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Anthera Pharmaceuticals logo — Pioneering Therapeutics to Combat Inflammatory Diseases, Pio...

Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Founded 2004 Post Ipo Equity Total: $101.50M Biotechnology, Health Care +1

General Information

Company Name Anthera Pharmaceuticals
Founded Year 2004
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Anthera Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anthera Pharmaceuticals

Anthera Pharmaceuticals, founded in 2004, is a development stage biopharmaceutical company with a focus on creating and bringing to market therapeutics for inflammation-related diseases. The company's main product candidates, including varespladib methyl (A-002) and varespladib sodium (A-001), target cardiovascular and autoimmune disorders. Anthera Pharmaceuticals holds license agreements with Eli Lilly and Company, Shionogi & Co., Ltd., and Amgen Inc. to develop and commercialize treatments for various diseases. With a last investment of $15.00M in post-IPO equity at 10 January 2018, the company is headquartered in Hayward, California. Anthera Pharmaceuticals is pioneering therapeutics to combat inflammatory diseases and aiming to pioneer better health in the biotechnology, healthcare, and pharmaceutical industries.

Taxonomy: Biopharmaceutical, Therapeutics, Inflammatory Diseases, Cardiovascular Disorders, Autoimmune Disorders, Clinical Trials, Drug Development, B-cell Mediated Autoimmune Diseases, Sickle Cell Disease, Eli Lilly and Company, Shionogi & Co., Ltd., Amgen Inc., Healthcare Innovation, Research and Development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 10 Jan 2018
Post-IPO Debt •••••• 1
Investor
01 Jan 2011
Post-IPO Equity •••••• 2
Investor Investor
21 Sep 2010
Venture Round •••••• 6
Investor Investor Investor Investor
•••• •••• 		14 Aug 2008
Venture Round •••••• 1
Investor
13 Sep 2006

Anthera Pharmaceuticals Alternatives & Competitors

Anthera Pharmaceuticals vs
Kyverna Therapeutics
Kyverna Therapeutics United States

Harnessing the power of cell therapy in autoimmune disease.

IPO
160 employees
Anthera Pharmaceuticals vs
Tmunity Therapeutics
Tmunity Therapeutics

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse arr...

Acquired
12 employees
Biotechnology, Health Care
Anthera Pharmaceuticals vs
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. United States

Leading the Next Frontier of Cell Therapy

Corporate Round
65 employees
Biotechnology, Health and Wellness

FAQ About Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health
Anthera Pharmaceuticals was founded in 2004.
Anthera Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Anthera Pharmaceuticals has completed 5 funding rounds, raising a total of $101.50M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Anthera Pharmaceuticals include Kyverna Therapeutics, Tmunity Therapeutics, Sonoma Biotherapeutics, Inc., Oryzon Genomics SA, advanceCor GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anthera Pharmaceuticals and Kyverna Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anthera Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy